1 Li F, "Transcriptional analysis of human survivin gene expression" 344 (344): 305-311, 1999
2 Osada S, "The utility of vitamin K3(menadione)against pancreatic cancer" 28 : 45-50, 2008
3 De Almagro MC, "The inhibitor of apoptosis(IAP)proteins are critical regulators of signaling pathways and targets for anti-cancer therapy" 34 : 200-211, 2012
4 Mobahat M, "Survivin as a preferential target for cancer therapy" 15 : 2494-2516, 2014
5 Altieri DC, "Survivin apoptosis : an interloper between cell death and cell proliferation in cancer" 79 : 1327-1333, 1999
6 Chen X, "Survivin and tumorigenesis : molecular mechanisms and therapeutic strategies" 7 : 314-323, 2016
7 Sah NK, "Structural, functional and therapeutic biology of survivin" 244 : 164-171, 2006
8 Gritsko T, "Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells" 12 : 11-19, 2006
9 Esteve PO, "Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells" 282 : 2615-2625, 2007
10 Al-Suhaimi E, "Molecular mechanisms of leptin and pro-apoptotic signals induced by menadione in HepG2 cells" 21 : 582-588, 2014
1 Li F, "Transcriptional analysis of human survivin gene expression" 344 (344): 305-311, 1999
2 Osada S, "The utility of vitamin K3(menadione)against pancreatic cancer" 28 : 45-50, 2008
3 De Almagro MC, "The inhibitor of apoptosis(IAP)proteins are critical regulators of signaling pathways and targets for anti-cancer therapy" 34 : 200-211, 2012
4 Mobahat M, "Survivin as a preferential target for cancer therapy" 15 : 2494-2516, 2014
5 Altieri DC, "Survivin apoptosis : an interloper between cell death and cell proliferation in cancer" 79 : 1327-1333, 1999
6 Chen X, "Survivin and tumorigenesis : molecular mechanisms and therapeutic strategies" 7 : 314-323, 2016
7 Sah NK, "Structural, functional and therapeutic biology of survivin" 244 : 164-171, 2006
8 Gritsko T, "Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells" 12 : 11-19, 2006
9 Esteve PO, "Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells" 282 : 2615-2625, 2007
10 Al-Suhaimi E, "Molecular mechanisms of leptin and pro-apoptotic signals induced by menadione in HepG2 cells" 21 : 582-588, 2014
11 Tetef M, "Mitomycin C and menadione for the treatment of lung cancer : a phase II trial" 13 : 157-162, 1995
12 Li MX, "Mitochondria and apoptosis : emerging concepts" 7 : 42-, 2015
13 Tariq M, "Menadione protects gastric mucosa against ethanol-induced ulcers" 56 : 393-399, 2005
14 Kim YJ, "Menadione induces the formation of reactive oxygen species and depletion of GSH-mediated apoptosis and inhibits the FAK-mediated cell invasion" 387 : 799-809, 2014
15 Lee MH, "Menadione induces apoptosis in a gastric cancer cell line mediated by down-regulation of X-linked inhibitor of apoptosis" 9 : 2437-2443, 2016
16 Lee MH, "Menadione induces G2/M arrest in gastric cancer cells by down-regulation of CDC25C and proteasome mediated degradation of CDK1 and cyclin B1" 8 : 5246-5255, 2016
17 Hassan GS, "Menadione" 38 : 227-313, 2013
18 Torre LA, "Global cancer statistics, 2012" 65 : 87-108, 2015
19 Romero-Gallo J, "Effect of Helicobacter pylori eradication on gastric carcinogenesis" 88 : 328-336, 2008
20 Tang C, "Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis" 20 : 249-258, 2009
21 Span PN, "Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?" 52 : 1693-1700, 2006
22 Igney FH, "Death and anti-death : tumour resistance to apoptosis" 2 : 277-288, 2002
23 Oztopcu-Vatan P, "Cytotoxic and apoptotic effects of menadione on rat hepatocellular carcinoma cells" 67 : 1003-1009, 2015
24 Chantalat L, "Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions" 6 : 183-189, 2000
25 Li F, "Control of apoptosis and mitotic spindle checkpoint by survivin" 396 : 580-584, 1998
26 Siegel RL, "Cancer statistics" 66 : 7-30, 2016